INTRODUCTION
In 1967 Lund, Padgett, and Ott reported that cyclic neutropenia occurs as an autosomal recessive disorder of grey collie dogs (1) . They observed that grey collies develop severe neutropenia at 12-day intervals and suggested that these dogs might serve as a model for studying cyclic neutropenia in man. Since an understanding of cyclic neutropenia may also provide information concerning the control mechanisms of leukopoiesis, we have initiated detailed studies of the formation and fate of neutrophils (PMN)' in grey collies (2) . The present studies indicate that the cyclic neutropenia is due to a regularly recurring failure of PMN production.
-METHODS Dogs. 12 grey collie dogs of both sexes were acquired from eight breeders in six states. There were four pairs of littermates. Serious and often fatal pyogenic infections frequently occurred when the dogs were neutropenic. Consequently, only three dogs survived longer than 6 months. Most of the observations reported were made on these longer surviving animals. Normal purebred collies with no history of grey forebears were used as controls except as indicated.
Blood counts. Venous blood samples anticoagulated with EDTA were obtained daily at 1:00 p.m. White blood cell (WBC) counts were made using an electronic particle counter2 and 100 cell differential counts were done on airdried, Wright's stained smears.
Bone marrow. Under light sodium thiamylal 3 anesthesia, aspirates of bone marrow were taken from the iliac crest or upper femur on 8 days of the 12-day cycle of one grey collie and at 3-day intervals of a cycle of two other grey collies. Differential counts of 300-500 nucleated cells were made on Wright's stained smears. Bone marrow biopsies were obtained from similar sites at 3-day intervals in one dog. Formalin-fixed, decalcified, Giemsa-stained specimens were examined.
Marrow neutrophil reserves. Hourly blood PMN counts were made for 6 hr following intravenous administration of Escherichia coli -127 :B8 endotoxin' (3) . A dose-response curve determined by testing eight mongrel dogs at weekly intervals indicated that 0.1 ,ug/kg produced an initial granulocytopenia and marked increase in the number of circulating nonsegmented PMN. The maximum increase in the blood PMN over 6 hr following this dose of endotoxin was used as a measure of the marrow PMN reserves.
Tritiated thymidine ('HTdR)-labeling indices. Marrow precursor-labeling indices were determined by the method of Mauer (4) with minor modifications. The nucleated cell concentration of heparinized marrow-aspirate samples was adjusted with Hank's solution to 2.0 X 106/ml. 1 ml of cell suspension was incubated with 2.5 ,uCi/ml 'HTdR' (SA 27.8 ,uCi/ml) for (7) . Because PMN are more highly labeled by DF3P than other leukocytes (7), these methods were assumed to measure PMN distribution and survival under the circumstances tested (blood PMN of 65-85%). These methods have also been shown to be applicable to neutropenic patients (8) . Under light sodium thiamylal anesthesia, approximately 10% of the animal's blood volume was collected in a plastic bag containing 37 ml of acid citrate dextrose anticoagulant. After the addition of 100 ,tCi of DF'3P 9, the blood was gently mixed at room temperature for 1 hr and then reinfused over 15 min. 12-ml heparinized venous blood samples were obtained from the bag before reinfusion and at 1, 3, 6, 12, and 24 hr. Dextran-sedimented leukocytes were separated from platelets by centrifugation at 200 g for 3 min and the erythrocytes removed by hypotonic lysis. The number of separated WBC were counted and the cells then digested in 0.2 N NaOH for 2 hr at 60'C. The digested material was acidified with 10% acetic acid and solubilized in a Bio-Solv (BB5-3)'0-Liquifluor '-Toluene cocktail 1" and the sample radioactivities were measured with a liquid scintillation counter '. The specific activity for each sample was expressed as counts/minute per cell. The slope and half-life for the leukocyte specific activity decay curves were calculated by the method of least squares (9) . The total body PMN pool, marginating and circulating pools, and PMN turnover rates were measured by extrapolating the specific activity decay curves to time zero and applying the formulae of Athens et al. (10) .
Combining the data on 18 cycles for four grey collies, a rate of decrease of the blood PMN count was calculated for the 3 days before the most neutropenic day of the cycle using PMN counts made at the same time each day. The line of best fit was determined by the method of least squares (9 Because no marrow element seems to remain constant, it is not possible to express the absolute quantitative fluctuations in the marrow cell populations. Nevertheless, examination of many aspirates as well as marrow biopsies taken at 3-day intervals strongly suggest that there are fewer myeloid precursors in the period before neutropenia occurs.
Marrow reserves. The neutrophil response to endotoxin on different cycle days for one grey collies is illustrated in Fig. 3 . These studies were performed no more than once per week to avoid the development of endotoxin "tolerance" (11) . As can be seen, there was no response during the neutropenic phase. The response was maximal just after the return of blood PMN and gradu- dogs gave the same results as the data presented in Fig. 6 . Leukokinetic studies. DF'P leukokinetic data are shown in Table I . Grey collies were studied by autologous labeling when their blood leukocyte differential counts were similar to the normal control dogs (12) . At this time the blood PMN half-lives were slightly longer than the normals (Table I ). In one grey collie entering the neutropenic phase and in another already neutropenic, the injection of PMN from normal collies had a normal survival. The number of dogs large enough for these investigations has been limited; nevertheless, the studies performed have not suggested a shortened neutrophil survival to be a mechanism for the development of neutropenia. The total blood PMN pool, the circulating pools, and PMN turnover rates were normal for autologous cells in the normal phase, but the marginating pool was increased. In the neutropenic phase, transfused normal collie cells had a normal half-life, but the various pools sizes were decreased (Table I) .
The rate of decrease of the blood PMN, expressed as PMN half-life as the dogs enter the neutropenic period, is slower than the normal collie PMN half-life measured by the DFS'P technique. This slow rate of decrease of the blood PMN count is further evidence, albeit indirect, that neutropenia does not occur by a mechanism that rapidly decreases the circulating PMN count. In Fig. 1 it can also be seen that the PMN count declines steadily for about 3 days before each neutropenic period.
DISCUSSION
These studies clearly indicate that cyclic neutropenia occurs in grey collie dogs because they fail to maintain a steady rate of PMN production. Myelopoiesis in these animals is characterized by periodic bursts in xmyelopoietic activity. They regularly develop neutropenia when they have exhausted their marrow neutrophil reserves. Then, as if stimulated by the development of neutropenia, they repeat the burst of myelopoietic activity.
Most of the data of these studies relate to the periodic increases in myelopoiesis. This activity is reflected by several parameters. First, the marow histology shows the orderly appearance of myeloid precursors of increasing maturity during the neutropenic phase. These cells rapidly mature to metamyelocytes and mature PMN. Second, the labeling indices of the myeloid precursors are increased above that expected for normal dog marrow (5) and above that observed at other times for the same dogs. Third, the serum muramidase, which indirectly reflects marrow myelopoietic activity (13) , rises just before the return of blood PMN. These dogs also have increased numbers of monocytes in the blood heralding the return of PMN, as seen in a recovering marrow under many circumstances (14) . Under these circumstances, the rise in serum muramidase might be due to either the change in PMN or monocyte production or both. Finally, we have recently reported (15) that these dogs have high levels of urinary colony-stimulatory activity for mouse marrow (16) during this phase of active myelopoiesis.
After the recovery from neutropenia, during a second phase of the neutrophil cycle, the dogs have a normal or increased blood PMN count for 6 or 7 days. During this period the PMN make a slight dip and peak before neutropenia recurs (Fig. 1) . No explanation for this "biphasic" phenomenon is apparent, but it is conceivable that this is an attempt to regulate the blood PMN count toward the normal level (17) . Marrow reserve tests at this second phase indicate a very large marrow neutrophil reserve, consistent with the marrow histology for this phase of the cycle. The half-life and distribution of circulating PMN are near normal, and at this time the dogs are also generally well.
The decline in PMN before neutropenia recurs is gradual. The rate of decrease (half-life = 11.4 hr) is very similar to that observed by Thomas for lethally irradiated dogs (half-life = 13 hr) (18) . These data, the normal survival of homologous transfused PMN, and the fact that serum muramidase falls to low levels several days before the PMN count begins to fall, all indicate that the development of neutropenia is not related to accelerated cell removal.
The data presented here and other studies of myelopoiesis in dogs (19, 20) suggest that the failure of proliferation occurs during the phase when blood PMN counts are normal. In these studies, marrow promyelocytes and myelocytes are scarce during the latter part of this phase. This concept is also supported by the detailed studies in dogs of Maloney and Patt (19) and Boggs et al. (20) , which indicated that 5-8 days are required for the generation of blood PMN from early precursors. Although a failure of the marrow to maintain PMN production seems to be the primary defect, the mechanism for the marrow failure is presently unknown.
In man, cyclic neutropenia occurs generally with 21-day cycles. Several studies have shown, primarily by serial marrow examinations (21, 22) , that a single wave of myeloid proliferation occurs with each blood PMN cycle. Meuret and Fliedner recently reported (22) that 3HTdR administered intravenously during the neutropenic phase appeared more rapidly than normal in the circulating PMN, indicating a more rapid than normal movement of cells from the proliferative through the maturational marrow pools in the recovery phase. The other concomitants of the proliferative phase seen in the dogs have not been reported for human cyclic neutropenia; however, cyclic fluctuations of serum muramidase have been seen in patients with induced periodic marrow failure and recovery due to intermittent cytosinearabinoside therapy (23) .
We," and others, have observed that blood PMN halflife is normal or slightly prolonged in patients with cy-"Dale, D. C., and S. M. Wolff. In preparation.
clic neutropenia when they have their highest PMN counts (22, 24) . Kinetic studies in the neutropenic phase are technically difficult due to the lack of cells to label, but the blood PMN count in yuan, as in the dogs, falls gradually with the neutropenic phase. Despite minor differences between the cyclic neutropenia of grey collie dogs and man, these peculiar dogs are an excellent model for the study of the human disease.
